These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of neural networks in brain SPECT to diagnose Alzheimer's disease. Page MP; Howard RJ; O'Brien JT; Buxton-Thomas MS; Pickering AD J Nucl Med; 1996 Feb; 37(2):195-200. PubMed ID: 8667044 [TBL] [Abstract][Full Text] [Related]
3. Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity. Warkentin S; Ohlsson M; Wollmer P; Edenbrandt L; Minthon L Dement Geriatr Cogn Disord; 2004; 17(3):207-14. PubMed ID: 14739546 [TBL] [Abstract][Full Text] [Related]
4. Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT. Holman BL; Carvalho PA; Mendelson J; Teoh SK; Nardin R; Hallgring E; Hebben N; Johnson KA J Nucl Med; 1991 Jun; 32(6):1206-10. PubMed ID: 2045934 [TBL] [Abstract][Full Text] [Related]
5. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. Holman BL; Garada B; Johnson KA; Mendelson J; Hallgring E; Teoh SK; Worth J; Navia B J Nucl Med; 1992 Jul; 33(7):1312-5. PubMed ID: 1613571 [TBL] [Abstract][Full Text] [Related]
6. Gender differences in cerebral perfusion in cocaine abuse: technetium-99m-HMPAO SPECT study of drug-abusing women. Levin JM; Holman BL; Mendelson JH; Teoh SK; Garada B; Johnson KA; Springer S J Nucl Med; 1994 Dec; 35(12):1902-9. PubMed ID: 7989967 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a neural-network classifier for PET scans of normal and Alzheimer's disease subjects. Kippenhan JS; Barker WW; Pascal S; Nagel J; Duara R J Nucl Med; 1992 Aug; 33(8):1459-67. PubMed ID: 1634935 [TBL] [Abstract][Full Text] [Related]
9. Quantitative brain SPECT in Alzheimer's disease and normal aging. Johnson KA; Kijewski MF; Becker JA; Garada B; Satlin A; Holman BL J Nucl Med; 1993 Nov; 34(11):2044-8. PubMed ID: 8229257 [TBL] [Abstract][Full Text] [Related]
10. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. Perani D; Di Piero V; Vallar G; Cappa S; Messa C; Bottini G; Berti A; Passafiume D; Scarlato G; Gerundini P J Nucl Med; 1988 Sep; 29(9):1507-14. PubMed ID: 3261784 [TBL] [Abstract][Full Text] [Related]
11. Neural-network classification of normal and Alzheimer's disease subjects using high-resolution and low-resolution PET cameras. Kippenhan JS; Barker WW; Nagel J; Grady C; Duara R J Nucl Med; 1994 Jan; 35(1):7-15. PubMed ID: 8271062 [TBL] [Abstract][Full Text] [Related]
12. Three-dimensional display of surface cortical perfusion by SPECT: application in assessing Alzheimer's disease. Hashikawa K; Matsumoto M; Moriwaki H; Oku N; Okazaki Y; Seike Y; Uehara T; Tanabe H; Ohie Y; Kamada T J Nucl Med; 1995 Apr; 36(4):690-6. PubMed ID: 7699466 [TBL] [Abstract][Full Text] [Related]
13. Neural-network-based classification of cognitively normal, demented, Alzheimer disease and vascular dementia from single photon emission with computed tomography image data from brain. deFigueiredo RJ; Shankle WR; Maccato A; Dick MB; Mundkur P; Mena I; Cotman CW Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5530-4. PubMed ID: 7777543 [TBL] [Abstract][Full Text] [Related]
14. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users. Holman BL; Mendelson J; Garada B; Teoh SK; Hallgring E; Johnson KA; Mello NK J Nucl Med; 1993 May; 34(5):723-7. PubMed ID: 8478703 [TBL] [Abstract][Full Text] [Related]
15. An easy Z-score imaging system for discrimination between very early Alzheimer's disease and controls using brain perfusion SPECT in a multicentre study. Matsuda H; Mizumura S; Nagao T; Ota T; Iizuka T; Nemoto K; Kimura M; Tateno A; Ishiwata A; Kuji I; Arai H; Homma A Nucl Med Commun; 2007 Mar; 28(3):199-205. PubMed ID: 17264779 [TBL] [Abstract][Full Text] [Related]
16. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls. Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246 [TBL] [Abstract][Full Text] [Related]
17. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions. Smith FW; Besson JA; Gemmell HG; Sharp PF J Cereb Blood Flow Metab; 1988 Dec; 8(6):S116-22. PubMed ID: 2973469 [TBL] [Abstract][Full Text] [Related]